Carregant...

Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7

BACKGROUND—The anti-idiotypic monoclonal antibody 105AD7 mimics the tumour associated antigen 791Tgp72, expressed on 70-80% of colorectal cancers. Phase I studies have shown that the vaccine is non-toxic, and a number of patients have been immunised prior to resection of their primary tumours.
AIMS—...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Maxwell-Armstrong, C, Durrant, L, Robins, R, Galvin, A, Scholefield, J, Hardcastle, J
Format: Artigo
Idioma:Inglês
Publicat: 1999
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1727698/
https://ncbi.nlm.nih.gov/pubmed/10486371
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!